dalteparin has been researched along with Brain Embolism and Thrombosis in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Röttger, C | 1 |
Madlener, K | 1 |
Heil, M | 1 |
Gerriets, T | 1 |
Walberer, M | 1 |
Wessels, T | 1 |
Bachmann, G | 1 |
Kaps, M | 1 |
Stolz, E | 1 |
Macdonald, RL | 1 |
Amidei, C | 1 |
Baron, J | 1 |
Weir, B | 1 |
Brown, F | 1 |
Erickson, RK | 1 |
Hekmatpanah, J | 1 |
Frim, D | 1 |
Liu, JT | 1 |
Paul, W | 1 |
Emerson, M | 1 |
Cicala, C | 1 |
Page, CP | 1 |
1 trial available for dalteparin and Brain Embolism and Thrombosis
Article | Year |
---|---|
Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy.
Topics: Adult; Aged; Anticoagulants; Combined Modality Therapy; Craniotomy; Dalteparin; Female; Heparin; Hum | 2003 |
2 other studies available for dalteparin and Brain Embolism and Thrombosis
Article | Year |
---|---|
Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis.
Topics: Abciximab; Angiography; Animals; Antibodies, Monoclonal; Anticoagulants; Blood Platelets; Chlorides; | 2005 |
Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
Topics: Amino Acid Chloromethyl Ketones; Animals; Anticoagulants; Antithrombins; Blood Platelets; Boron Comp | 1994 |